NCT00001270
- Conditions
- Breast Diseases, Breast Neoplasms, Endocrine Gland Neoplasms, +25 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
1,466 public trials
175 recruiting studies
Lymphoma trial results
Completed
Pegfilgrastim PBPC Mobilization Study
NCT00066092
- Conditions
- Hematology, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
- Locations
-
Not specified
NCT00536393
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Clinique Victor Hugo Le Mans, France
NCT00320827
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT00136552
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium
- Hôpital Henri Mondor Créteil, France
- Hôpital Saint Louis Paris, France
- Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite, France
NCT00086034
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- San Diego, California, United States
- Stanford, California, United States
- Miami, Florida, United States
- Chicago, Illinois, United States
Completed
Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.
NCT00299780
- Conditions
- Acute Myelogenous Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- MD Anderson Cancer Center Houston, Texas, United States
Completed
Dose Reduction in Thoracic CT
NCT00188461
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Toronto General Hospital Toronto, Ontario, Canada
NCT00001579
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Completed
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
NCT00035022
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States